For example, treatment with fenofibrate, a PPARα agonist that is known to enhance FAO in T cells, leads to improved function of CD8 T cells cultured in hypoglycemic and hypoxic conditions, and of tumor infiltrating lymphocytes from tumor-bearing mice treated with fenofibrate and transplanted to secondary recipients [166]. Here, PPARA is linked to neoplasm.